Browsing Tag
Osteoporosis
8 posts
Prolia and Xgeva just got rivals: FDA clears BILDYOS and BILPREVDA biosimilars for U.S. launch
The FDA has approved Henlius and Organon’s denosumab biosimilars. Find out what this means for U.S. bone health access, pricing, and investor sentiment.
Biocon (NSE: BIOCON) gains EU nod for Denosumab biosimilars Vevzuo and Evfraxy to target bone health market
Biocon Biologics receives EU approval for Denosumab biosimilars Vevzuo and Evfraxy. Find out how this milestone could reshape its European biosimilars strategy.
Calcium: A critical mineral for health and vitality
Calcium plays an indispensable role in maintaining the structural integrity and overall functionality of the human body. While…
How to strengthen your bones and prevent osteoporosis
Osteoporosis, a condition where bones become brittle and fragile due to a loss of bone mass, is a…
Zydus Lifesciences’ Menostar Transdermal System generic gets FDA final approval
Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System…
Biocon Biologics signs licensing deal for two biosimilars with Yoshindo
Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo…
Haoma Medica completes first-in-human trial of NaQuinate, a promising osteoporosis treatment
Haoma Medica, a UK-based biotechnology company, has successfully wrapped up the first-in-human clinical trial of NaQuinate, a novel…
Amgen and UCB resubmit BLA for EVENITY to transform osteoporosis treatment in postmenopausal women
Amgen, in collaboration with UCB, has announced the resubmission of the biologics license application (BLA) for their osteoporosis…